tradingkey.logo
tradingkey.logo
Search

Outlook Therapeutics Inc

OTLK
Add to Watchlist
1.350USD
+0.030+2.28%
Close 07-23 16:00ETQuotes delayed by 15 min
141.24MMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-23
Previous score
3.00
Change
0
The current institutional shareholding score of Outlook Therapeutics Inc is 3.00, ranking 192 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 8.33%, representing a quarter-over-quarter increase of 40.96%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.24% of shares outstanding, with 50.66% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
GMS Ventures and Investments
13.55M
+46.25%
Schonfeld Strategic Advisors LLC
715.17K
-47.60%
Gilpin Wealth Management LLC
354.20K
--
BlackRock Institutional Trust Company, N.A.
365.34K
+10.62%
Geode Capital Management, L.L.C.
306.30K
+15.31%
Marshall Wace LLP
298.46K
--
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.